Table of Contents

2019-2024 Global POC Diagnostics Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global POC Diagnostics Consumption 2014-2024
  • 2.1.2 POC Diagnostics Consumption CAGR by Region
• 2.2 POC Diagnostics Segment by Type
  • 2.2.1 Blood Glucose Testing
  • 2.2.2 Infectious Diseases Testing
  • 2.2.3 Cardiac Markers Testing
  • 2.2.4 Coagulation Testing
  • 2.2.5 Pregnancy and Fertility Testing
  • 2.2.6 Blood Gas/Electrolytes Testing
  • 2.2.7 Tumor Markers Testing
  • 2.2.8 Urinalysis Testing
  • 2.2.9 Cholesterol Testing
• 2.3 POC Diagnostics Consumption by Type
  • 2.3.1 Global POC Diagnostics Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global POC Diagnostics Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global POC Diagnostics Sale Price by Type (2014-2019)
• 2.4 POC Diagnostics Segment by Application
  • 2.4.1 Clinics
  • 2.4.2 Hospitals
  • 2.4.3 Laboratory
  • 2.4.4 Others
• 2.5 POC Diagnostics Consumption by Application
  • 2.5.1 Global POC Diagnostics Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global POC Diagnostics Value and Market Share by Application (2014-2019)
  • 2.5.3 Global POC Diagnostics Sale Price by Application (2014-2019)

3 Global POC Diagnostics by Players

• 3.1 Global POC Diagnostics Sales Market Share by Players
  • 3.1.1 Global POC Diagnostics Sales by Players (2017-2019)
  • 3.1.2 Global POC Diagnostics Sales Market Share by Players (2017-2019)
• 3.2 Global POC Diagnostics Revenue Market Share by Players
  • 3.2.1 Global POC Diagnostics Revenue by Players (2017-2019)
  • 3.2.2 Global POC Diagnostics Revenue Market Share by Players (2017-2019)
• 3.3 Global POC Diagnostics Sale Price by Players
• 3.4 Global POC Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global POC Diagnostics Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players POC Diagnostics Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 POC Diagnostics by Regions

• 4.1 POC Diagnostics by Regions
  • 4.1.1 Global POC Diagnostics Consumption by Regions
  • 4.1.2 Global POC Diagnostics Value by Regions
• 4.2 Americas POC Diagnostics Consumption Growth
• 4.3 APAC POC Diagnostics Consumption Growth
• 4.4 Europe POC Diagnostics Consumption Growth
• 4.5 Middle East & Africa POC Diagnostics Consumption Growth

5 Americas

• 5.1 Americas POC Diagnostics Consumption by Countries
  • 5.1.1 Americas POC Diagnostics Consumption by Countries (2014-2019)
  • 5.1.2 Americas POC Diagnostics Value by Countries (2014-2019)
• 5.2 Americas POC Diagnostics Consumption by Type
• 5.3 Americas POC Diagnostics Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC POC Diagnostics Consumption by Countries
  • 6.1.1 APAC POC Diagnostics Consumption by Countries (2014-2019)
  • 6.1.2 APAC POC Diagnostics Value by Countries (2014-2019)
• 6.2 APAC POC Diagnostics Consumption by Type
• 6.3 APAC POC Diagnostics Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe POC Diagnostics by Countries
  • 7.1.1 Europe POC Diagnostics Consumption by Countries (2014-2019)
  • 7.1.2 Europe POC Diagnostics Value by Countries (2014-2019)
• 7.2 Europe POC Diagnostics Consumption by Type
• 7.3 Europe POC Diagnostics Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa POC Diagnostics by Countries
  • 8.1.1 Middle East & Africa POC Diagnostics Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa POC Diagnostics Value by Countries (2014-2019)
• 8.2 Middle East & Africa POC Diagnostics Consumption by Type
• 8.3 Middle East & Africa POC Diagnostics Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 POC Diagnostics Distributors
• 10.3 POC Diagnostics Customer

11 Global POC Diagnostics Market Forecast

• 11.1 Global POC Diagnostics Consumption Forecast (2019-2024)
• 11.2 Global POC Diagnostics Forecast by Regions
  • 11.2.1 Global POC Diagnostics Forecast by Regions (2019-2024)
  • 11.2.2 Global POC Diagnostics Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global POC Diagnostics Forecast by Type
• 11.8 Global POC Diagnostics Forecast by Application

12 Key Players Analysis

• 12.1 Alere
  • 12.1.1 Company Details
  • 12.1.2 POC Diagnostics Product Offered
  • 12.1.3 Alere POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Alere News
• 12.2 Roche
  • 12.2.1 Company Details
  • 12.2.2 POC Diagnostics Product Offered
  • 12.2.3 Roche POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Roche News
• 12.3 Abbott Laboratories
  • 12.3.1 Company Details
  • 12.3.2 POC Diagnostics Product Offered
  • 12.3.3 Abbott Laboratories POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Abbott Laboratories News
• 12.4 Johnson & Johnson
  • 12.4.1 Company Details
  • 12.4.2 POC Diagnostics Product Offered
  • 12.4.3 Johnson & Johnson POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Johnson & Johnson News
• 12.5 Siemens Healthcare
  • 12.5.1 Company Details
  • 12.5.2 POC Diagnostics Product Offered
  • 12.5.3 Siemens Healthcare POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Siemens Healthcare News
• 12.6 Danaher
  • 12.6.1 Company Details
  • 12.6.2 POC Diagnostics Product Offered
  • 12.6.3 Danaher POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Danaher News
• 12.7 Bayer Healthcare
  • 12.7.1 Company Details
  • 12.7.2 POC Diagnostics Product Offered
  • 12.7.3 Bayer Healthcare POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Bayer Healthcare News
• 12.8 Beckman Coulter
  • 12.8.1 Company Details
  • 12.8.2 POC Diagnostics Product Offered
  • 12.8.3 Beckman Coulter POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Beckman Coulter News
• 12.9 Nipro Diagnostics
  • 12.9.1 Company Details
  • 12.9.2 POC Diagnostics Product Offered
  • 12.9.3 Nipro Diagnostics POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Nipro Diagnostics News
• 12.10 Bio-Rad Laboratories
  • 12.10.1 Company Details
  • 12.10.2 POC Diagnostics Product Offered
  • 12.10.3 Bio-Rad Laboratories POC Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Bio-Rad Laboratories News
• 12.11 Nova Biomedical
• 12.12 BioMerieux
• 12.13 Quidel
• 12.14 Helena Laboratories
• 12.15 OraSure Technologies
• 12.16 Accriva
• 12.17 Abaxis
• 12.18 Chembio Diagnostics
• 12.19 Trinity Biotech

13 Research Findings and Conclusion

Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Currently, there are more companies enter into POC Diagnostics industry in the world, especially in USA. The main market players are, Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, etc.

Alere is the largest supplier of POC Diagnostics, with the revenue market share about 18% in 2015, and the top 6 supplier of POC Diagnostics, with the revenue market share about 68% in 2015. That is to say, the industry of POC Diagnostics is relative concentration.

There are nine kinds of POC Diagnostics, which are Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing and Cholesterol Testing. Blood Glucose Testing is wildly used in the POC Diagnostics, with a revenue market share nearly 46% in 2015. The fastest-growing segment, Cardiac Markers Testing, is projected to increase at a CAGR of 13%.

POC Diagnostics is used in Clinics, Hospitals, Laboratory and Others. Report data showed that 42.3% of the POC Diagnostics market demand in Clinics application, 34.4% in Hospitals application, and 4.9% in Laboratory application in 2015.

Development Tendency
Briefly speaking, in the next few years, POC Diagnostics industry will still be a highly energetic industry. Revenue of POC Diagnostics have brought a lot of opportunities there will more companies enter into this industry, especially in developing countries.

According to this study, over the next five years the POC Diagnostics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in POC Diagnostics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of POC Diagnostics market by product type, application, key manufacturers and key regions and countries.

This study considers the POC Diagnostics value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Clinics
Hospitals
Laboratory
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global POC Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of POC Diagnostics market by identifying its various subsegments.
Focuses on the key global POC Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the POC Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of POC Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.